Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of ocular surface changes after switching to preservative-free tafluprost + timolol fixed combination
TCTR20220225004Phase 4Unknown
- Sponsor
- Department of Ophthalmology, Faculty of Medicine, Chiang Mai University
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tafluprost + timolol in Glaucoma, ocular hypertension, sponsored by Department of Ophthalmology, Faculty of Medicine, Chiang Mai University. Status: unknown.
02
Drugs
tafluprost + timolol
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on TCTR20220225004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220225004.